Assessing the Long-term Effects of Wearing a Lower-limb Exoskeleton on Physical Activity and Quality of Life in Pre-frail Adults - a Feasibility Study
Exoskeleton
Prevention Study
Summary
Study start date: September 6, 2023
Actual date on which the first participant was enrolled.This study focuses on exploring how wearing a lower-limb exoskeleton over an extended period affects physical activity levels and quality of life in older adults who are considered pre-frail. Pre-frail individuals may exhibit signs of frailty such as weight loss, slower mobility, or reduced physical activity, making it challenging to maintain a healthy lifestyle. The study acknowledges that as people age, they may experience walking difficulties that impact their daily activities and overall well-being. Exoskeletons, which are wearable devices that assist with walking, have shown promise in improving walking speed, reducing energy expenditure, and preventing falls. This research is important as it seeks to determine if the benefits of using these devices are sustainable over time, which could significantly enhance the independence and quality of life for older adults. In this interventional study, participants will wear a non-invasive passive hip exoskeleton consistently for 12 weeks. The study aims to evaluate changes in their walking patterns and overall mobility by analyzing specific characteristics of their gait. Additionally, the research will assess whether the improvements in physical activity and quality of life persist for six weeks after they stop using the exoskeleton. This will involve tracking how the participants move and their ability to engage in daily activities. By understanding the long-term effects of exoskeleton use, the study hopes to provide insights into new ways to support older adults in maintaining active and independent lifestyles.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.16 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 65 to 85 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location